HOME ZACKS RESEARCH FUNDS PORTFOLIO BROKER RESEARCH MARKETS SCREENING EDUCATION SERVICES
Earnings    EPS Surprises    Mutual Funds    Options    My Account    Help    

Profit from the Pros – Zacks Free Email Newsletter
Our free email newsletter is filled with timely stock picks and market commentary. Sign up for free. Already on board? Check out the archive.
Quote:
Login Free Membership
Search:

Top Zacks Features
Free Membership
Premium Home
Zacks Rank
Equity Research
My Portfolio
Stock Screener
Profit Tracks
Mutual Funds
Options
Zacks Video
RSS Feed
Profit from the Pros

Subscription Services
Product Guide
Zacks Premium
Zacks Elite
Method for Trading
Chart Patterns Trader
Double Your Money
ETF Trader
Growth Trader
Options Trader
Small Cap Trader
Strategic Investor
Surprise Trader
Top 10 Stocks
Value Trader
Special Reports
Research Wizard

Zacks Premium
Get profitable stock
picks and timely
market advice in
Zacks.com`s Free
Daily Newsletter!

Free Registration

View the Archive


CNMD: Conmed Cp - Full Company Report Enter Ticker:
 

QuoteEstimatesCharts Company ReportsNewsFinancials
  Full Company Report |  Estimates |  Brokerage Recommendations |  Comparison to Industry |  Insiders |  Brokerage Reports |  Zacks Equity Research   |  Annual Report
CONMED CP (NASD)
CNMD 21.46 -0.11 (-0.51%) Vol.  113,756 16:00 ET
CONMED Corporation is a medical technology company specializing in instruments and implants for arthroscopic sports medicine, and powered surgical instruments, such as drills and saws, for orthopaedic, ENT and neurosurgery. The company is also a leading developer, manufacturer and supplier of advanced medical devices, including electrosurgical systems, electrodes for heart monitoring. The company's products are used in a variety of clinical settings, such as operating rooms, surgery centers, physicians' offices and critical care areas of hospitals.

 General Information
CONMED CORP
525 French Road
Utica, NY 13502
Phone: 315 797-8375
Fax: 315 797-0321
Web: www.conmed.com
Email: info@conmed.com
 
Industry MED/DENTAL-SUPP
Sector: Medical
 
Fiscal Year End December
Last Reported Quarter 09/30/09
Next EPS Date 02/04/2010
 
 Price and Volume Information
Zacks Rank
Yesterday's Close 21.57
52 Week High 25.54
52 Week Low 11.56
Beta 0.91
20 Day Moving Average 188,155.70
Target Price Consensus 25.75
 
 % Price Change
4 Week -4.07
12 Week 19.69
YTD -10.36
 % Price Change Relative to S&P 500
4 Week -5.10
12 Week 12.84
YTD -25.81
 Share Information
Shares Outstanding (millions) 29.08
Market Capitalization (millions) 624.16
Short Ratio 9.17
Last Split Date 09/10/2001
 Dividend Information
Dividend Yield 0.00%
Annual Dividend $0.00
Payout Ratio 0.00
Change in Payout Ratio 0.00
Last Dividend Payout / Amount NA / $0.00

 EPS Information
Current Quarter EPS Consensus Estimate 0.32
Current Year EPS Consensus Estimate 0.94
Estimated Long-Term EPS Growth Rate -
Next EPS Report Date 02/04/2010
 Consensus Recommendations
Current (1=Strong Buy, 5=Strong Sell) 2.50
30 Days Ago 3.50
60 Days Ago 2.67
90 Days Ago 2.67

 Fundamental Ratios
 P/E
Current FY Estimate: 22.75
Trailing 12 Months: 21.90
PEG Ratio -
 EPS Growth
vs. Previous Year -24.32%
vs. Previous Quarter 64.71%
 Sales Growth
vs. Previous Year -2.19%
vs. Previous Quarter: 6.63%
 Price Ratios
Price/Book 1.09
Price/Cash Flow 8.05
Price / Sales 0.91
 ROE
09/30/09 5.11
06/30/09 5.69
03/31/09 7.17
 ROA
09/30/09 3.03
06/30/09 3.34
03/31/09 4.14
 Current Ratio
09/30/09 3.91
06/30/09 4.58
03/31/09 4.44
 Quick Ratio
09/30/09 1.87
06/30/09 2.05
03/31/09 1.98
 Operating Margin
09/30/09 4.15
06/30/09 4.55
03/31/09 5.42
 Net Margin
09/30/09 3.83
06/30/09 5.72
03/31/09 8.01
 Pre-Tax Margin
09/30/09 3.83
06/30/09 5.72
03/31/09 8.01
 Book Value
09/30/09 19.62
06/30/09 19.40
03/31/09 19.10
 Inventory Turnover
09/30/09 2.18
06/30/09 2.18
03/31/09 2.21
 Debt-to-Equity
09/30/09 0.32
06/30/09 0.33
03/31/09 0.34
 Debt to Capital
09/30/09 24.27
06/30/09 24.64
03/31/09 25.19

 
About Zacks | Advertise | Media | Careers | Contact Us | Help
Disclaimer | Privacy Policy | Sitemap
NYSE and AMEX data is at least 20 minutes delayed.  NASDAQ data is at least 15 minutes delayed.
Copyright 2009 Zacks Investment Research